Kazakhstan signs an agreement to purchase four million doses of the Pfizer–BioNTech COVID-19 vaccine which will be delivered in the fourth quarter of this year
Kazakhstan signs an agreement to purchase four million doses of the Pfizer–BioNTech COVID-19 vaccine which will be delivered in the fourth quarter of this year.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthKazakhstan signs an agreement to purchase four million doses of the Pfizer–BioNTech COVID-19 vaccine which will be delivered in the fourth quarter of this year
View Premium plansBrowse free archive reportsKazakhstan signs an agreement to purchase four million doses of the Pfizer–BioNTech COVID-19 vaccine which will be delivered in the fourth quarter of this year.